恒瑞医药(01276)11月11日斥资915.26万元回购15万股A股

Core Viewpoint - Heng Rui Medicine (01276) announced a share buyback plan, intending to repurchase 150,000 A-shares at a cost of 9.1526 million yuan, scheduled for November 11, 2025 [1] Company Summary - The company is engaging in a share repurchase, which indicates a strategy to enhance shareholder value and potentially signal confidence in its future performance [1] - The total amount allocated for the buyback is 9.1526 million yuan, reflecting the company's commitment to returning capital to shareholders [1]